Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Transplanting growing hair follicles into scars can help regenerate and improve scar tissue.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Recent selection on immune response genes was identified across seven ethnicities.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Dermal papilla cells help wounds heal better and can potentially grow new hair.

Tiny vesicles from stem cells could be a new treatment for healing wounds.